|
|
CrossRef Text and Data Mining | |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. | |
The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma | |
Sang Hee Park, Yun Jeong Lee, Jung-Eun Cheon, Choong Ho Shin, Hae Woon Jung, Young Ah Lee | |
Ann Pediatr Endocrinol Metab. 2023;28(2):107-115. Published online June 30, 2022 DOI: https://doi.org/10.6065/apem.2244046.023 |
|
The effect of hypothalamic involvement and growth hormone treatment on cardiovascular risk factors during the transition period in patients with childhood-onset craniopharyngioma The Effect of Hypothalamic Involvement and Growth Hormone Treatment on Cardiovascular Risk Factors in Patients With Childhood-Onset Craniopharyngioma Growth hormone replacement therapy during transition of patients with childhood-onset growth hormone deficiency into adulthood: What are the issues? P03-31 Factors affecting IGF-I response to Growth Hormone (GH) replacement therapy during transition in patients with childhood-onset GH deficiency Eating behaviour and oxytocin in patients with childhood‐onset craniopharyngioma and different grades of hypothalamic involvement SAT-461 Long-Term Effects of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (Hit-Endo) OR11,63 Growth hormone treatment has a positive effect on spine bone mineral density in young adults with childhood-onset growth hormone deficiency: a meta-analysis Growth hormone and cardiovascular risk factors Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency |